Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Fixed-dose, Clinical Study of Quinacrine Safety and Efficacy in the Treatment of Advanced Renal Cell Carcinoma

NCT00574483 is registered in ClinicalTrials.gov with Cleveland BioLabs as lead sponsor.

NCT NCT00574483
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00574483 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Fixed-dose, Clinical Study of Quinacrine Safety and Efficacy in the Treatment of Advanced Renal Cell Carcinoma
Lead sponsor
Cleveland BioLabs
Phase
Phase 2
Overall status
Withdrawn
Start date
November 30, 2007
Completion date
January 31, 2008
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

renal cell carcinoma